Predictive Oncology and Integra Therapeutics form collaboration focused on gene therapy

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

In May, the American Society of Clinical Oncology released guidelines on the use of germline genetic testing panels in concert with tumor testing for cancer patients. xxx:more

June 07, 2024

Vol.50 No.23

By Rebecca Sutphen

Clinical Trials & Tribulations

Are we focused on the wrong risk type in genetic screening?
Breast cancer screening study shows new paths to population screening

A common perception of genetic screening is that only individuals at high risk of certain diseases will be identified.

UChicago Cancer Luminaries Podcast: Todd Golub discusses mentorship, interdisciplinary research

Todd Golub, director and founding core member of the Broad Institute of MIT and Harvard, appeared on the Cancer Luminaries podcast, a series launched by the UChicago Medicine Comprehensive Cancer Center to mark its 50th year as a National Cancer Institute-designated center.

May 10, 2024

Vol.50 No.19

Clinical Roundup

AI harnesses tumor genetics to predict treatment response

Scientists at University of California San Diego School of Medicine used a machine learning algorithm to predict when cancer will resist chemotherapy.

January 19, 2024

Vol.50 No.03

Clinical Roundup

Mount Sinai researchers find more than 4,700 gene clusters crucial for prognosis in 32 cancer types

Researchers at the Mount Sinai Center for Transformative Disease Modeling have released a groundbreaking study identifying 4,749 key gene clusters, termed “prognostic modules,” that significantly influence the progression of 32 different types of cancer.

November 17, 2023

Vol.49 No.43

Clinical Roundup

187 novel genetic variants linked to prostate cancer, revising what is known about genetic risk

An international collaboration led by USC compiled the most comprehensive list of genetic variants associated with prostate cancer risk through a whole-genome analysis that ranks as the largest and most diverse investigation into prostate cancer genetics yet.

November 10, 2023

Vol.49 No.42

Predictive Oncology and Integra Therapeutics form collaboration focused on gene therapy

YOU MAY BE INTERESTED IN

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

Are we focused on the wrong risk type in genetic screening?
Breast cancer screening study shows new paths to population screening

UChicago Cancer Luminaries Podcast: Todd Golub discusses mentorship, interdisciplinary research

AI harnesses tumor genetics to predict treatment response

Mount Sinai researchers find more than 4,700 gene clusters crucial for prognosis in 32 cancer types

187 novel genetic variants linked to prostate cancer, revising what is known about genetic risk

Renew today!

Subscriber content

Login

Predictive Oncology and Integra Therapeutics form collaboration focused on gene therapy

YOU MAY BE INTERESTED IN

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

Are we focused on the wrong risk type in genetic screening?Breast cancer screening study shows new paths to population screening

UChicago Cancer Luminaries Podcast: Todd Golub discusses mentorship, interdisciplinary research

AI harnesses tumor genetics to predict treatment response

Mount Sinai researchers find more than 4,700 gene clusters crucial for prognosis in 32 cancer types

187 novel genetic variants linked to prostate cancer, revising what is known about genetic risk

Login

Are we focused on the wrong risk type in genetic screening?
Breast cancer screening study shows new paths to population screening